**Core Concept**
Erythromycin is a macrolide antibiotic that also has prokinetic properties. Its prokinetic effect is primarily due to its action on the gastrointestinal tract, specifically by stimulating intestinal motility.

**Why the Correct Answer is Right**
Erythromycin stimulates intestinal motility by acting as a motilin receptor agonist. Motilin is a hormone that regulates the interdigestive migrating motor complex (IMMC), which helps to clear the stomach and small intestine of residual food and fluids. By stimulating motilin receptors, erythromycin increases the frequency and amplitude of the IMMC, thereby enhancing gastrointestinal motility.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because erythromycin's prokinetic effect is not primarily due to its antimicrobial properties.
**Option B:** This option is incorrect because erythromycin does not increase gastric acid secretion.
**Option C:** This option is incorrect because erythromycin does not have a significant effect on intestinal secretion.

**Clinical Pearl / High-Yield Fact**
Erythromycin is often used off-label to treat diabetic gastroparesis, a condition characterized by delayed gastric emptying in patients with diabetes mellitus. Its use in this context is based on its ability to stimulate gastric motility and improve symptoms such as nausea and vomiting.

**Correct Answer: C. Erythromycin's prokinetic effect is due to its action on motilin receptors.**